Vitamin Deficiency
Adverse Events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse Events should also be reported to Kyowa Kirin International UK NewCo Ltd, known as Grünenthal Meds on +44 (0)1896 664000, email PVUK@grunenthalmeds.com
Vitamins B&C Kyowa Kirin Intravenous High Potency, Concentrate for Solution for Infusion
Find out about Vitamins B&C Kyowa Kirin IVHP, a rapid parenteral therapy for treating thiamine deficiency, including those related to alcohol misuse and malnutrition.1
Vitamins B&C Kyowa Kirin IVHP is indicated in adults and children for rapid therapy of severe depletion or malabsorption of the water soluble vitamins B and C:1
- Particularly in alcoholism, where a severe depletion of thiamine can lead to Wernicke’s encephalopathy
- After acute infections
- Post-operatively
- In psychiatric states
Click here for prescribing information.
-
INTRODUCTION
Find out more about treating patients with Vitamins B&C Kyowa Kirin IVHP: a parenteral therapy for treating thiamine deficiency that can help reverse the early changes in the brain caused by thiamine deficiency.1-3
-
MODE OF ACTION
Find out more about why Vitamins B&C Kyowa Kirin IVHP is critical in the treatment of thiamine deficiency for the prevention of alcohol related brain damage seen in Wernicke's encephalopathy.2
-
RESOURCES
Access resources, recommendations and guidance information, along with useful information on alcohol use and Wernicke's encephalopathy.
-
HOW TO PRESCRIBE
Guidance on how to prescribe Vitamins B&C Kyowa Kirin IVHP, including dosing, frequency and duration.
-
TOLERABILITY
Guidance on the most commonly reported side effects and adverse drug reactions.1
-
PRESCRIBING INFORMATION
Direction on prescribing Vitamins B&C Kyowa Kirin IVHP, covering information from dosing to precautions and contraindications.
-
References List label
1. Vitamins B&C Kyowa Kirin Intravenous High Potency, Concentrate for Solution for Infusion Summary of Product Characteristics.
2. Thomson AD, et al. Alcohol Alcohol. 2002; 37(6): 513-521.
3. Thomson AD. Alcohol Alcohol. 2000; 35(1): 2-7.
KKI/GB/PAB/0259 June 2024